HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Funding Cited As Barrier To Developing Animal Alternatives At Meeting

This article was originally published in The Rose Sheet

Executive Summary

Lack of funding is one of the primary barriers to implementing use of alternative toxicological methods in the U.S., according to participants at an International Society of Regulatory Toxicology and Pharmacology workshop in Baltimore, Md. Nov. 17-18

You may also be interested in...



Animal Alternative Reg Improvements Should Be Considered – Report

Improvements to the regulatory process for accepting animal alternative test methods by the European Union and the Organization for Economic Cooperation and Development should be considered to ensure the timely acceptance of validated test methods for cosmetics, according to a report by an ad hoc group of European regulators and stakeholders

Dr. Hauschka Expands Cosmetics Lineup, Repackages For Fall

Dr. Hauschka Skin Care is introducing new products and repackaging several existing items under its Decorative Cosmetics line, according to the holistic skin care company

Rimmel London Launches Moisture Cream Lipstick, Lycra Mascara

Rimmel Rich Moisture Cream Lipstick contains Moisture-Lock Complex which improves the natural barrier function of lips to lock in moisture, according to Rimmel London

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel